Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2013 | 09-2012 | 09-2011 | 09-2010 | 09-2007 | |
| Sales | 32,053 | 41,706 | 41,882 | 22,763 | 0 |
| Gross Profit | 32,053 | 41,706 | 41,882 | 22,763 | N/A |
| Operating Expenses | 23,024 | 20,417 | 16,583 | 15,821 | 0 |
| Operating Income | 9,029 | 21,289 | 25,299 | 6,942 | N/A |
| Interest Expense | 31 | 0 | 3,161 | 0 | 0 |
| Other Income | 629 | 110 | 1,172 | 805 | 0 |
| Pre-tax Income | 9,627 | 21,399 | 23,310 | 7,747 | 0 |
| Income Tax | N/A | N/A | N/A | -157 | N/A |
| Net Income Continuous | 9,627 | 21,399 | 23,310 | 7,904 | N/A |
| Net Income | $9,627 | $21,399 | $23,310 | $7,904 | $N/A |
| EPS Basic Total Ops | -0.67 | 1.26 | 1.40 | 0.19 | N/A |
| EPS Basic Continuous Ops | 0.98 | 19.65 | 20.83 | 6.99 | N/A |
| EPS Diluted Total Ops | -0.67 | 1.13 | 1.32 | 0.18 | N/A |
| EPS Diluted Continuous Ops | 0.98 | 8.65 | 12.55 | 5.05 | N/A |
| EBITDA(a) | $10,512 | $22,051 | $26,115 | $7,495 | $N/A |